7h
Hosted on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...
We recently published a list of the Top 12 Luxury Clothing Stocks to Buy According to Hedge Funds. In this article, we are ...
Manufacturing in the U.S. would help European designer brands skirt a tariff war. Luckily, shoppers don’t seem too attached ...
HousingWire's Tech100 award program, now in its 13th year, celebrates groundbreaking companies shaping the future of housing finance. View Argyle's complete company profile and learn more about the ...
Technology disruption, post-globalization, and shifting profit pools will drive dealmaking in the year ahead as interest rates and regulatory c ...
Bain Capital Specialty Finance, Inc. Prices Public Offering of $350 Million 5.950% Senior Notes Due 2030 ...
With the Fed's two-day FOMC meeting concluding yesterday, no offerings were priced in the IG primary, leaving weekly IG issuance so far to date at US$11.67bn, according to IFR data. But that will ...
Alluvial Fund completed the year in quiet fashion, rising 0.7%, ahead of the Russell 2000 (RTY). Click here to read the full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results